Compounds > iproniazid
Page last updated: 2024-10-29

iproniazid and Adrenal Cancer

iproniazid has been researched along with Adrenal Cancer in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Iproniazid was discontinued."5.43[Pseudo-pheochromocytoma due to iproniazid: A case report]. ( Dollfus, S; Fedrizzi, S; Lecardeur, L; Loggia, G; Nathou, C; Tréhout, M, 2016)
"Iproniazid was discontinued."1.43[Pseudo-pheochromocytoma due to iproniazid: A case report]. ( Dollfus, S; Fedrizzi, S; Lecardeur, L; Loggia, G; Nathou, C; Tréhout, M, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tréhout, M1
Fedrizzi, S1
Loggia, G1
Lecardeur, L1
Nathou, C1
Dollfus, S1

Other Studies

1 other study available for iproniazid and Adrenal Cancer

ArticleYear
[Pseudo-pheochromocytoma due to iproniazid: A case report].
    La Revue de medecine interne, 2016, Volume: 37, Issue:2

    Topics: Adrenal Gland Neoplasms; Aged; Humans; Iproniazid; Male; Monoamine Oxidase Inhibitors; Pheochromocyt

2016